( November 3, 2025, 9:26 AM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court granted the manufacturer of the diabetes drug Actos more time to file its petition for a writ of certiorari to challenge a Ninth Circuit U.S. Court of Appeals decision that found no error in the certification of a class of national third-party payers (TPPs)....